Story
BUSINESS · NOV 19, 2026
Sanofi Considers Acquisition of US Drugmaker Insmed
Sanofi is consulting with advisers regarding a potential acquisition of Insmed, causing the US drugmaker's shares to rise 14 percent.
Sanofi is weighing the acquisition of the U.S. drugmaker Insmed, according to a report from Bloomberg News. The French pharmaceutical company is currently consulting with advisers to study the potential deal, though deliberations remain ongoing and a final agreement may be weeks away.
Shares of Insmed rose 14 percent following the report, bringing the company's market valuation to $26.28 billion. Sanofi has declined to comment on the matter, stating it does not respond to market rumors, and Insmed has not yet provided a comment.
Reported across 5 outlets
Actors
SanofiInsmed